₹45

▼ -2.5 -5.26%

As of 05 Aug 2026 · delayed

NSE Listed · Pharmaceuticals

Zenith Drugs Limited (ZENITHDRUG)

Volume: 7,200Avg Vol 1W: 4,800Avg Vol 1M: 6,25552W Range:₹33.3₹76

NSE BSE www.zenithdrugs.com AI Report

Key Ratios

Checked 10h ago

Market Cap—

Current Price₹45

Previous Close₹47.5

High / Low (52w)₹76 / ₹33.3

Volume7,200

Avg Vol (1W)4,800

Avg Vol (1M)6,255

Stock P/E21.3

Book Value₹43.69

Dividend Yield—

ROE—

ROA—

Revenue (TTM)—

Revenue Growth—

Profit Margin—

Total Debt₹9 Cr

Shares Outstanding—

Face Value—

EPS (TTM)₹2.3

P/B1.12

Debt / Equity0.63

50 DMA₹46.61

200 DMA₹48.56

Day change-5.26%

Price Chart

₹45▼ 33.18% · 1Y

2025-08-06

2026-08-05

20-day avg volume: 5K shares

Pros

Company is almost debt-free.

Profit & Loss (Annual)

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Revenue	₹78 Cr	₹74 Cr	₹93 Cr	₹116 Cr	₹134 Cr
EBITDA	₹6 Cr	₹6 Cr	₹7 Cr	₹9 Cr	₹18 Cr
Net Profit	₹3 Cr	₹3 Cr	₹3 Cr	₹5 Cr	₹10 Cr
EPS	85	76.66	78.22	122.02	5.63

Balance Sheet

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Total Assets	₹44 Cr	₹47 Cr	₹69 Cr	₹98 Cr	₹135 Cr
Total Liabilities	₹37 Cr	₹37 Cr	₹56 Cr	₹80 Cr	₹73 Cr
Equity	₹7 Cr	₹10 Cr	₹12 Cr	₹18 Cr	₹62 Cr
Total Debt	₹6 Cr	₹7 Cr	—	—	—

Cash Flow

Metric	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operating	₹0 Cr	₹6 Cr	₹-3 Cr	₹-9 Cr
Investing	₹-1 Cr	₹-5 Cr	₹0 Cr	₹26 Cr
Financing	₹3 Cr	₹1 Cr	₹5 Cr	₹-4 Cr
Free Cash Flow	₹0 Cr	₹6 Cr	₹-3 Cr	₹-9 Cr

Efficiency & Working Capital

ROCE12.7%

Interest Coverage5.5

Dividend Payout—

Debtor Days168 d

Inventory Days64 d

Payable Days106 d

Cash Conversion Cycle126 d

Working Capital Days232 d

Shareholding Details

As of 2026-03-31

Promoter70%

FII0%

DII0%

Institutions0%

Public30%

Promoter Pledge0%

No. of Shareholders1,435

Shareholding Pattern

Quarterly — figures in %. Latest 8 quarters.

Period	Sept 2023	Feb 2024	Feb 2024	Mar 2024	Sept 2024	Mar 2025	Sept 2025	Mar 2026
Promoters	100%	70%	70%	70%	70%	70%	70%	70%
FIIs	0%	7.4%	7.4%	5.8%	0.4%	0.1%	0%	0%
DIIs	0%	3.7%	0.1%	0%	0%	0%	0%	0%
Public	0%	18.9%	22.5%	24.2%	29.6%	30%	30%	30%
Promoter Pledge	0%	0%	0%	0%	0%	0%	0%	0%
No. of Shareholders	7	1,333	1,333	1,117	1,355	1,544	1,466	1,435

Returns History (ROE / ROCE / ROA)

Period	ROE	ROCE	ROA	P/E
202503	—	—	—	—

Major Shareholders (>1%)

Name	Category	Stake	Shares
Ajay Singh Dassundi	Shareholding of Promoter and Promoter Group	22.5%	38,61,990
Sandeep Bhardwaj	Shareholding of Promoter and Promoter Group	21.4%	36,66,990
Bhupesh Soni	Shareholding of Promoter and Promoter Group	20.2%	34,60,980
Jaywanti Soni	Shareholding of Promoter and Promoter Group	2.9%	5,04,000
Priyanka Bharadwaj	Shareholding of Promoter and Promoter Group	1.9%	3,33,000
Anjali Dassundi	Shareholding of Promoter and Promoter Group	0.8%	1,38,000
Saroj Soni	Shareholding of Promoter and Promoter Group	0.2%	35,040

Board of Directors

Name	Designation	Year
SANDEEP BHARDWAJ	Executive Director & MD	2025
BHUPESH SONI	Executive Director	2025
Ajay Singh Dassundi	Executive Director	2025
Deendayal Kumawat	Independent Non Exe. Director	2025
Anil Malik	Non Executive Director	2025
RANJANA SEHGAL	Independent Non Exe. Director	2025
Sakshi Bhawsar	Company Sec. & Compli. Officer	2025

Segments — Product

Segment	Revenue	Share
Manufacturing and trading of medici	₹0 Cr	—

Segments — Geography

Region	Revenue	Share
Domestic	₹133 Cr	99.7%
Export	₹0 Cr	0.3%

Capital Structure (₹ Cr)

Year	Face Value	Authorised	Issued	Paid-up
2025	₹10	22	17	17

Related-Party Transactions (₹ Cr)

Year	KMP	Others	Total
2025	8	62	70
2025	0	7	7
2025	8	54	62

More stocks

Zaggle Prepaid Ocean Services Ltd.Arco Leasing Ltd.Zeal Global Services Ltd.Zee Entertainment Enterprises Ltd.Zee Learn Zee Media Corporation Zenith Exports Ltd.Zenith Steel Pipes & Industries Ltd.Zensar Technologies Ltd.Zen Technologies Limited ZF Commercial Vehicle Control System India Ltd.Z F Steering Gear (India) Ltd.All “Z” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search